A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

NCT00317174 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Tetanus
Whole Cell Pertussis
Hepatitis B
Diphtheria

Interventions

BIOLOGICAL: DTPw-HBV/Hib-MenAC conjugate vaccine

Sponsor

GlaxoSmithKline